Patient-Centric Mission. Asset-Centric Approach. We’re pursuing our Orexin Receptor 2 Agonist Program to bring potentially transformative treatment options to patients with sleep-wake, neurological, neurodegenerative and neuropsychiatric disorders.... Backed by Foresite Capital.
About the role
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- 12+ years of pharmaceutical or biotechnology industry experience with broad CMC expertise across Drug Substance, Drug Product, Analytical Development, and Regulatory CMC
- Scientific background with strong technical writing and communication skills
- Understanding of phase-appropriate documentation to support CMC development, including regulatory guidelines and filing requirements
- Ability to simplify complex scientific terminology into high-level take home narratives for ease of review
- Proficient with document management tools
More about this role
Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists as a new class of medicines for the treatment of narcolepsy and potentially other sleep-wake disorders. Centessa’s lead investigational candidate – cleminorexton (formerly ORX750) – is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. Centessa's OX2R agonist portfolio includes additional clinical and preclinical-stage assets with potential utility across a broader range of neurological, neurodegenerative, and neuropsychiatric conditions.
Headquartered in Boston, Massachusetts, Centessa was recognized as a Great Place to Work ® in 2026.
The CMC Technical Writer role will critically review data, methods, batch records, and various development, campaign, and production reports from external CDMOs to finalize source documents for analytical, drug substance and drug product. The CMC Technical Writer should also then be able to write scientific and regulatory content and author and prepare report summaries and conclusions from the source documents for final document repository.
- Translate data,...
Browse similar: Startup jobs · Boston